Read + Share
Amedeo Smart
Independent Medical Education
Huang Z, Hu X, Wei Y, Lai Y, et al. ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification. PLoS One 2024;19:e0303909.PMID: 38814950
Email
LinkedIn
Privacy Policy